The PRINCIPLE randomised controlled open label platform trial of hydroxychloroquine for treating COVID19 in community based patients at high risk.
Saved in:
| Title: | The PRINCIPLE randomised controlled open label platform trial of hydroxychloroquine for treating COVID19 in community based patients at high risk. |
|---|---|
| Authors: | Hobbs FDR; Nuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, UK. Richard.hobbs@phc.ox.ac.uk., Dorward J; Nuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, UK., Hayward G; Nuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, UK., Yu LM; Nuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, UK., Saville BR; Berry Consultants, Austin, TX, USA.; Department of Biostatistics, Vanderbilt University School of Medicine, Nashville, TN, USA., Butler CC; Nuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, UK. Christopher.butler@phc.ox.ac.uk. |
| Corporate Authors: | PRINCIPLE Investigators |
| Source: | Scientific reports [Sci Rep] 2025 Jul 04; Vol. 15 (1), pp. 23850. Date of Electronic Publication: 2025 Jul 04. |
| Publication Type: | Journal Article; Randomized Controlled Trial |
| Journal Info: | Publisher: Nature Publishing Group Country of Publication: England NLM ID: 101563288 Publication Model: Electronic Cited Medium: Internet ISSN: 2045-2322 (Electronic) Linking ISSN: 20452322 NLM ISO Abbreviation: Sci Rep Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| ISSN: | 2045-2322 |
|---|---|
| DOI: | 10.1038/s41598-025-09275-6 |
